Table 1. Patient characteristics.

	N	%	Median	Range
Age at study entry			51	(15–76)
Gender
Male	9	18
Female	41	82
Tumour type
Breast adenocarcinoma	20	40
Sarcoma	19	38
Melanoma	6	12
Ovarian adenocarcinoma	2	4
Colorectal adenocarcinoma	1	2
Pancreatic adenocarcinoma	1	2
Non-small cell lung cancer	1	2
Prior lines of chemotherapy/MTA			3	(0–8)
Type of last treatment received
Chemotherapy±MTA	32	64
MTA	5	10
Hormone therapy	3	6
None	10	20

Abbreviation: MTA=molecularly targeted agent.